Correlation Between Sumitomo Chemical and SCANDMEDICAL SOLDK-040

Can any of the company-specific risk be diversified away by investing in both Sumitomo Chemical and SCANDMEDICAL SOLDK-040 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sumitomo Chemical and SCANDMEDICAL SOLDK-040 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sumitomo Chemical and SCANDMEDICAL SOLDK 040, you can compare the effects of market volatilities on Sumitomo Chemical and SCANDMEDICAL SOLDK-040 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sumitomo Chemical with a short position of SCANDMEDICAL SOLDK-040. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sumitomo Chemical and SCANDMEDICAL SOLDK-040.

Diversification Opportunities for Sumitomo Chemical and SCANDMEDICAL SOLDK-040

0.2

Correlation Coefficient

Sumitomo Chemical  SCANDMEDICAL SOLDK-040

Modest diversification

The 3 months correlation between Sumitomo and SCANDMEDICAL is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Sumitomo Chemical and SCANDMEDICAL SOLDK 040 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCANDMEDICAL SOLDK 040 and Sumitomo Chemical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sumitomo Chemical are associated (or correlated) with SCANDMEDICAL SOLDK-040. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCANDMEDICAL SOLDK 040 has no effect on the direction of Sumitomo Chemical i.e., Sumitomo Chemical and SCANDMEDICAL SOLDK-040 go up and down completely randomly.

Pair Corralation between Sumitomo Chemical and SCANDMEDICAL SOLDK-040

Assuming the 90 days horizon Sumitomo Chemical is expected to generate 1.81 times less return on investment than SCANDMEDICAL SOLDK-040. But when comparing it to its historical volatility, Sumitomo Chemical is 1.59 times less risky than SCANDMEDICAL SOLDK-040. It trades about 0.07 of its potential returns per unit of risk. SCANDMEDICAL SOLDK 040 is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  52.00  in SCANDMEDICAL SOLDK 040 on April 20, 2025 and sell it today you would earn a total of  6.00  from holding SCANDMEDICAL SOLDK 040 or generate 11.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Sumitomo Chemical  vs.  SCANDMEDICAL SOLDK 040

Sumitomo Chemical

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Sumitomo Chemical are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Sumitomo Chemical may actually be approaching a critical reversion point that can send shares even higher in August 2025.

SCANDMEDICAL SOLDK 040

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in SCANDMEDICAL SOLDK 040 are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, SCANDMEDICAL SOLDK-040 reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sumitomo Chemical and SCANDMEDICAL SOLDK-040

The main advantage of trading using opposite Sumitomo Chemical and SCANDMEDICAL SOLDK-040 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sumitomo Chemical position performs unexpectedly, SCANDMEDICAL SOLDK-040 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCANDMEDICAL SOLDK-040 will offset losses from the drop in SCANDMEDICAL SOLDK-040's long position.

The idea behind Sumitomo Chemical and SCANDMEDICAL SOLDK 040 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.